Thus, we could infer that the RIP1/RIP3/MLKL pathway contributes to glutamate-induced NLRP3 inflammasome activation, and it may be one of the upstream regulators of NLRP3 inflammasome activation in glaucoma. The gene discussed is RIPK1; the disease is glaucoma.